Fatimata Bintou Sall

Fatimata Bintou Sall


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
DGDiego Germini
Diego Germini
FSFatimata Bintou Sall
Fatimata Bintou Sall
ASAnna Shmakova
Anna Shmakova
Joëlle WielsJoëlle Wiels
Joëlle Wiels
Svetlana DokudovskayaSvetlana Dokudovskaya
Svetlana Dokudovskaya
Yegor VassetzkyYegor Vassetzky
Yegor Vassetzky
Epstein Barr Virus (EBV) is one of the most common human herpesviruses. After primary infection, it can persist in the host throughout their lifetime in a latent form, from which it can reactivate following specific stimuli. EBV reactivation is triggered by transcriptional transactivator proteins ZEBRA (also known as Z, EB-1, Zta or BZLF1) and RTA (also known as BRLF1). Here we discuss the structural and functional features of ZEBRA, its role in oncogenesis and its possible implication as a prognostic or diagnostic marker. Modulation of host gene expression by ZEBRA can deregulate the immune surveillance, allow the immune escape, and favor tumor progression. It also interacts with host proteins, thereby modifying their functions. ZEBRA is released into the bloodstream by infected cells and can potentially penetrate any cell through its cell-penetrating domain; therefore, it can also change the fate of non-infected cells. The features of ZEBRA described in this review outline its importance in EBV-related malignancies.

31 January 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
FSFatimata Bintou Sall
Fatimata Bintou Sall
RARawan El Amine
Rawan El Amine
DMDiana Markozashvili
Diana Markozashvili
TTTatyana Tsfasman
Tatyana Tsfasman
EOEric Oksenhendler
Eric Oksenhendler
DGDiego Germini
Diego Germini

23 April 2016 in BMC Hematology
Verified
Journal Article
Open access
PDF file
ASAbibatou Sall
Abibatou Sall
ATAwa Oumar Touré
Awa Oumar Touré
FSFatimata Bintou Sall
Fatimata Bintou Sall
Moussa NdourMoussa Ndour
Moussa Ndour
SFSeynabou Fall
Seynabou Fall
MRMartine Raphaël
Martine Raphaël
Chronic lymphocytic leukemia (CLL) is a mature B-cell neoplasm characterized by the expansion of CD5-positive lymphocytes in peripheral blood. While CLL is the most common type of leukemia in Western populations, the disease is rare in Africans. Hence, clinical and laboratory data and studies of CLL in Sub Saharan populations have been limited. The aims of this study were to analyze the characteristics of senegalese patients with CLL at the time of the diagnosis and to identify the correlation between clinical characteristics (Binet stage) with age, gender, laboratory parameters and chromosomal abnormalities. In this study, we investigated the clinical and laboratory characteristics of CLL in Senegal. A total of 40 patients who had been diagnosed with CLL during the period from July 2011 to April 2015 in Senegal were evaluated. Cytology and immunophenotype were performed in all patients to confirm the diagnosis. The prognosis factors such as Binet staging, CD38 and cytogenetic abnormalities were studied. The statistical analysis was performed using STATA version 13 (Stata college station Texas). Each patient signed a free and informed consent form before participating in the study. The mean age was 61 years ranged from 48 to 85. There were 31 males and only 9 females (sex ratio M : F = 3,44). At diagnosic, 82.5 % of the patients were classified as having advanced Binet stages B or C. The prognosis marker CD38 was positive in 28 patients. Cytogenetic abnormalities studied by FISH were performed in 25 patients, among them, 68 % (17 cases) had at least one cytogenetic abnormality and 28 % had 2 simultaneous cytogenetic abnormalities. Africans may present with CLL at a younger age and our data suggest that CLL in Senegal may be more aggressive than in Western populations.

7 September 2015 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
ASAbibatou Sall
Abibatou Sall
ATAwa Oumar Touré
Awa Oumar Touré
FNFatou Samba Ndiaye
Fatou Samba Ndiaye
ASAbdoulaye Sène
Abdoulaye Sène
FSFatimata Bintou Sall
Fatimata Bintou Sall
SDSaliou Diop
Saliou Diop
RDD (Rosai Dorfman disease) is a rare and benign histiocytic proliferative disorder of unknown etiology. FNAC (Fine‐needle aspiration cytology) is a useful and reliable tool for the diagnosis of RDD, and as such, biopsy is avoidable.

16 April 2018 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
FSFatimata Bintou Sall
Fatimata Bintou Sall
DGDiego Germini
Diego Germini
AKA. P. Kovina
A. P. Kovina
VRV. Ribrag
V. Ribrag
Joëlle WielsJoëlle Wiels
Joëlle Wiels
Yegor VassetzkyYegor Vassetzky
Yegor Vassetzky
Chromosomal translocations have long been known for their association with malignant transformation, particularly in hematopoietic disorders such as B-cell lymphomas. In addition to the physiological...

30 December 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
FSFatimata Bintou Sall
Fatimata Bintou Sall
APAndrei Pichugin
Andrei Pichugin
OIOlga Iarovaia
Olga Iarovaia
ABAna Barat
Ana Barat
TTTatyana Tsfasman
Tatyana Tsfasman
DGDiego Germini
Diego Germini
Recurrent chromosomal translocations are found in many blood and solid cancers. Balanced translocations, frequent in lymphoid malignancies, lead to the formation of two aberrant derivative (der) chromosomes. This event often leads to overexpression of an oncogene. In many cases, the expression of an oncogene is not enough to produce a malignant phenotype; however, most part of the studies focus on the events involving the chromosome where the oncogene is located, but rarely the other der chromosome where other oncogenic alterations may potentially arise. Mantle cell lymphoma (MCL), an aggressive B-cell non-Hodgkin lymphoma, is a perfect example of this. In 85% of the cases, it is characterized by the translocation t(11;14), which leads to the overexpression of cyclin D1 (CCND1) gene which results juxtaposed to the immunoglobulin heavy chain (IGH) gene on the der14 chromosome. This feature alone is not sufficient to induce oncogenesis. Here we focused on the der11 chromosome. We demonstrated that expression of 88 genes located in a 15mb region close to the translocation breakpoint on the der11 was deregulated both in the GRANTA-519 MCL cell line and in B-cells from MCL patients. We found that a large segment of der11containing deregulated genes was relocated from its normal position in the nuclear periphery towards the center of the nucleus in close proximity to the nucleolus where the abundant nucleolar protein nucleolin binds a subset of genes located close to the breakpoint and activates their expression. This finding allowed to identify new potential oncogenes involved in MCL and the mechanisms of their upregulation.